{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:49Z","timestamp":1746417769860,"version":"3.40.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Bilateral kidney damage in hypertensive patients is not parallel. Angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker (ACEI\/ARB), as a commonly used antihypertensive drug, could protect kidney function and delay its deterioration. Most studies focused on overall renal function, but the researches on split renal function (SRF) are rare. We investigated the effects of ACEI\/ARB on the SRF in patients with primary hypertension.<\/jats:p>\n            <jats:p>Patients with primary hypertension (n\u200a=\u200a429; male: 213; female: 216) admitted to our department between January 2014 and December 2016 were included in this study. The glomerular filtration rate (GFR) of split and total renal function were determined using diethylenetriaminepentaacetic acid tagged with 99mTc renal dynamic imaging method. For the same patient, the side with high GFR was considered as higher GFR kidney, whereas that with a low GFR was considered as lower GFR kidney. The split function score (<jats:italic toggle=\"yes\">Q<\/jats:italic> value) was utilized to evaluate the differences of bilateral renal function. The patients were divided into 3 groups based on the <jats:italic toggle=\"yes\">Q<\/jats:italic> values (Group 1, <jats:italic toggle=\"yes\">Q<\/jats:italic> value &lt;5%; Group 2, <jats:italic toggle=\"yes\">Q<\/jats:italic> value of 5%\u201310%; Group 3, <jats:italic toggle=\"yes\">Q<\/jats:italic> value \u226510%). All the patients received antihypertensive therapy based on ACEI\/ARB. The renal dynamic imaging was performed in the 1-year follow-up to investigate the changes of the SRF.<\/jats:p>\n            <jats:p>Compared with the baseline level, significant decline was noticed in the serum creatinine (Scr) in Group 2 and Group 3 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .05). The cystatin C in Group 3 showed significant decline (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). Compared with the baseline, there was significant decline in the Q value in Group 2, whereas the GFR of lower GFR kidney showed significant increase (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). No statistical differences were noticed in the <jats:italic toggle=\"yes\">Q<\/jats:italic> value and split GFR in Group 1 and Group 3 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&gt;\u200a.05).<\/jats:p>\n            <jats:p>In primary hypertension patients, ACEI\/ARB therapy could improve the SRF of lower GFR kidney in the presence of certain differences between the SRF. As a result, the SRF difference was reduced. In case of <jats:italic toggle=\"yes\">Q<\/jats:italic> value in a range of 5% to 10%, ACEI\/ARB could improve the renal function effectively. It may be significant for the design of antihypertensive drugs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025928","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T15:01:14Z","timestamp":1621350074000},"page":"e25928","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker on the split renal function in the patients with primary hypertension"],"prefix":"10.1097","volume":"100","author":[{"given":"Jingsi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kehui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2537-4629","authenticated-orcid":false,"given":"Yanchun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2369-14-43","article-title":"Impact of acute kidney injury exposure period among liver transplantation patients","volume":"14","author":"Narciso","year":"2013","journal-title":"BMC Nephrol"},{"issue":"(supspl 6)","key":"R2-20250504","first-page":"153","article-title":"[Renin-angiotensin-aldosterone system]","volume":"62","author":"Suzuki","year":"2004","journal-title":"Nihon Rinsho"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/1753-0407.12616","article-title":"The kidney and cardiovascular outcome trials","volume":"10","author":"Bloomgarden","year":"2018","journal-title":"J Diabetes"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart Disease and Stroke Statistics-2017 Update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/M14-0488","article-title":"Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study","volume":"162","author":"Anderson","year":"2015","journal-title":"Ann Intern Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/s13104-016-2293-y","article-title":"Hypertension control and care at Mulago Hospital ambulatory clinic, Kampala-Uganda","volume":"9","author":"Ssinabulya","year":"2016","journal-title":"BMC Res Notes"},{"key":"R7-20250504","first-page":"35","article-title":"The angiotensin-II (AT-II) receptor blocker olmesartan reduces renal damage in animal models of hypertension and diabetes","volume":"48","author":"Pugsley","year":"2005","journal-title":"Proc West Pharmacol Soc"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1556\/2060.105.2018.1.7","article-title":"Swimming exercise demonstrates advantages over running exercise in reducing proteinuria and glomerulosclerosis in spontaneously hypertensive rats","volume":"105","author":"Totou","year":"2018","journal-title":"Physiol Int"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/ki.2010.550","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts","volume":"79","author":"Astor","year":"2011","journal-title":"Kidney Int"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.2174\/1381612823666170609084436","article-title":"Management of blood pressure and heart rate in patients with diabetes mellitus","volume":"23","author":"Gouni-Berthold","year":"2017","journal-title":"Curr Pharm Des"},{"key":"R11-20250504","first-page":"689360","article-title":"The renin-angiotensin-aldosterone system in vascular inflammation and remodeling","volume":"2014","author":"Pacurari","year":"2014","journal-title":"Int J Inflam"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1900\/RDS.2015.12.119","article-title":"Improvements in the management of diabetic nephropathy","volume":"12","author":"Dounousi","year":"2015","journal-title":"Rev Diabet Stud"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11906-018-0897-4","article-title":"Chronotherapy for hypertension","volume":"20","author":"Bowles","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/JLP.JLP_136_18","article-title":"Renoprotective effect of irbesartan in a rat model of gentamicin-induced nephrotoxicity: Role of oxidative stress","volume":"11","author":"Al-Kuraishy","year":"2019","journal-title":"J Lab Physicians"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12863-019-0802-4","article-title":"Associations between potentially functional CORIN SNPs and serum corin levels in the Chinese Han population","volume":"20","author":"Zhang","year":"2019","journal-title":"BMC Genet"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.ajkd.2004.11.012","article-title":"Application of GFR-estimating equations in Chinese patients with chronic kidney disease","volume":"45","author":"Zuo","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e9765","DOI":"10.1097\/MD.0000000000009765","article-title":"Assessment of the association between serum uric acid levels and the incidence of hypertension in nonmetabolic syndrome subjects: a prospective observational study","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1172\/JCI113880","article-title":"Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. elucidation of signal transduction pathways","volume":"83","author":"Badr","year":"1989","journal-title":"J Clin Invest"},{"key":"R20-20250504","first-page":"45","article-title":"The benefit of anti-inflammatory and renal-protective dietary ingredients on the biological processes of aging in the kidney","volume":"7","author":"Panickar","year":"2018","journal-title":"Biology (Basel)"},{"key":"R21-20250504","first-page":"2397638","article-title":"Microangiopathic hemolytic anemia and fulminant renal failure: a rare manifestation of pheochromocytoma","volume":"2019","author":"Sharma","year":"2019","journal-title":"Case Rep Endocrinol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/ajh\/hpw077","article-title":"Aldosterone-renin ratio and side-selective renal perfusion in essential hypertension","volume":"29","author":"Sch\u00fctten","year":"2016","journal-title":"Am J Hypertens"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/01.HYP.0000127787.85259.1f","article-title":"Reduced uteroplacental blood flow alters renal arterial reactivity and glomerular properties in the rat offspring","volume":"43","author":"Sanders","year":"2004","journal-title":"Hypertension"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/01.HYP.10.2.212","article-title":"Renal scintigraphic captopril test in the diagnosis of renovascular hypertension","volume":"10","author":"Fommei","year":"1987","journal-title":"Hypertension"},{"key":"R25-20250504","first-page":"11","article-title":"Molecular mechanisms underlying gallic acid effects against cardiovascular diseases: An update review","volume":"10","author":"Akbari","year":"2020","journal-title":"Avicenna J Phytomed"},{"key":"R26-20250504","first-page":"35","article-title":"[Organoprotective effects of the combination of perindopril and amlodipine depending on the renal functional state in patients with arterial hypertension]","volume":"91","author":"Iskenderov","year":"2013","journal-title":"Klin Med (Mosk)"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11906-002-0004-7","article-title":"Effect of ramipril versus amlodipine on renal outcomes in hypertensive nephrosclerosis","volume":"4","author":"Flack","year":"2002","journal-title":"Curr Hypertens Rep"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MNH.0000000000000557","article-title":"Mitigating risk of aldosterone in diabetic kidney disease","volume":"29","author":"Frimodt-M\u00f8ller","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/ndt\/gfg232","article-title":"An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settings","volume":"18","author":"Palmer","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jacc.2013.10.050","article-title":"Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease","volume":"63","author":"Molnar","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/ndt\/gfq792","article-title":"Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials","volume":"26","author":"Maione","year":"2011","journal-title":"Nephrol Dial Transplant"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:21:38Z","timestamp":1746339698000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":30,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025928","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"2020-08-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}